Eli Lilly & Co. (LLY): Price and Financial Metrics

LLY POWR Grades

• LLY scores best on the Quality dimension, with a Quality rank ahead of 92.17% of US stocks.
• LLY's strongest trending metric is Stability; it's been moving down over the last 26 weeks.
• LLY's current lowest rank is in the Momentum metric (where it is better than 10.86% of US stocks).

LLY Stock Summary

• LLY has a higher market value than 99.67% of US stocks; more precisely, its current market capitalization is $350,178,563,266.
• LLY's went public 36.96 years ago, making it older than 93.52% of listed US stocks we're tracking.
• With a price/sales ratio of 11.98, ELI LILLY & CO has a higher such ratio than 91.09% of stocks in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to ELI LILLY & CO are PFE, MRK, ABBV, NVO, and TSM.
• LLY's SEC filings can be seen here. And to visit ELI LILLY & CO's official web site, go to www.lilly.com.

LLY Valuation Summary

• In comparison to the median Healthcare stock, LLY's price/earnings ratio is 151.95% higher, now standing at 58.2.
• Over the past 243 months, LLY's price/earnings ratio has gone up 29.2.

Below are key valuation metrics over time for LLY.

LLY Growth Metrics

The year over year price growth rate now stands at 59.83%.
• Its 5 year net income to common stockholders growth rate is now at 102.12%.
• The 2 year revenue growth rate now stands at 27.01%.

Over the past 33 months, LLY's revenue has gone up $6,920,000,000.

The table below shows LLY's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	29,239.5	7,661.2	6,033.2
2022-06-30	29,070.7	7,107.7	5,691.6
2022-03-31	29,322.8	8,062.5	6,129.3
2021-12-31	28,318.4	7,260.7	5,581.7
2021-09-30	27,758.5	6,919.4	5,972.4
2021-06-30	26,726.3	7,094.7	6,070.7

LLY's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• LLY has a Quality Grade of B, ranking ahead of 90.11% of graded US stocks.
• LLY's asset turnover comes in at 0.586 -- ranking 60th of 681 Pharmaceutical Products stocks.
• BHC, VRTX, and DRRX are the stocks whose asset turnover ratios are most correlated with LLY.

The table below shows LLY's key quality metrics over time.